Table 2.
Survival analysis of DHHC and PPT mutant strains
Strain | n | Mean (days) | Median (days) | 90% mortality (days) | Maximum (days) |
---|---|---|---|---|---|
N2 | 184 | 20 | 19 | 26 | 28 |
dhhc-1 (tm4272) | 97 | 17* | 18 | 24† | 27 |
dhhc-2 (ok990) | 100 | 20 | 19 | 26 | 34 |
dhhc-9 (gk985) | 143 | 19* | 19 | 24 | 30 |
dhhc-12 (gk1013) | 50 | 19 | 20 | 26 | 26 |
dhhc-12 (gk981) | 93 | 21 | 21† | 26 | 28 |
dhhc-13 (gk36) | 93 | 21 | 20† | 26 | 28 |
dhhc-14 (gk330) | 49 | 18* | 18† | 20† | 24 |
dhhc-14 (ok1032) | 48 | 18* | 19 | 24† | 24 |
spe-10 (hc104) | 95 | 21 | 19 | 29 | 35 |
ppt-1 (gk131) | 88 | 21 | 20 | 28† | 33 |
ppt-1 (gk134) | 43 | 19 | 19 | 23 | 28 |
ppt-1 (gk139) | 86 | 19 | 19 | 27 | 30 |
ath-1 (ok1735) | 80 | 19 | 19 | 24† | 33 |
Various measures of survival were extracted from lifespan experiments comparing wild-type Bristol N2 and DHHC or PPT mutant strains. Statistical tests were applied to values varying from the control using OASIS [73]. * p < 0.01 by the log-rank (Mantel-Cox) test. † p < 0.01 by Fisher’s exact test.